Level C· Early human research exploring benefitsCase Report / SeriesPubMed

[Effects of three-dimensional bioprinting antibacterial hydrogel on full-thickness skin defect wounds in rats].

Jin RH., Zhang ZZ., Xu PQ., Xia SZ., Weng TT., Zhu ZK.

Case Report / Series with a reported sample of 6 on Chronic Wound, Scar, published in Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi (2023) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi (2023)
Country
China
Reported sample size
6
Source database
PubMed
PMID
36878526
PMCID
PMC11630339
DOI
10.3760/cma.j.cn501120-20210809-00274
Citations
6

Abstract (original English)

Objective: To explore the effects of three-dimensional (3D) bioprinting gelatin methacrylamide (GelMA) hydrogel loaded with nano silver on full-thickness skin defect wounds in rats. Methods: The experimental research method was adopted. The morphology, particle diameter, and distribution of silver nanoparticles in nano silver solution with different mass concentrations and the pore structure of silver-containing GelMA hydrogel with different final mass fractions of GelMA were observed by scanning electron microscope and the pore size was calculated. On treatment day 1, 3, 7, and 14, the concentration of nano silver released from the hydrogel containing GelMA with final mass fraction of 15% and nano silver with final mass concentration of 10 mg/L was detected by mass spectrometer. At 24 h of culture, the diameters of inhibition zone of GelMA hydrogel containing final mass concentration of 0 (no nano silver), 25, 50, and 100 mg/L nano silver against Staphylococcus aureus and Escherichia coli were detected. Fibroblasts (Fbs) and adipose stem cells (ASCs) were isolated respectively by enzymatic digestion using the discarded prepuce after circumcision from a 5-year-old healthy boy who was treated in the Department of Urology of the Second Affiliated Hospital of Zhejiang University School of Medicine in July 2020, and the discarded fat tissue after liposuction from a 23-year-old heal

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
MaleRatsAnimalsHumansHydrogelsBioprintingMetal NanoparticlesRats, Sprague-DawleySilverSoft Tissue Injuries

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research